Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2003
10/30/2003WO2003015608A3 Combination therapy for the treatment of cancer
10/30/2003WO2003012051A3 Inhibitor of dna methylation
10/30/2003WO2002103362A3 Cancer associated protein
10/30/2003WO2002103042A3 Method and nucleic acids for the differentiation of prostate tumors
10/30/2003WO2002102229A3 Diagnosing tumorigenicity and determining resistance to anticancer therapy
10/30/2003WO2002099041A3 Ces2s as modifiers of the p53 pathway and methods of use
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002085340A3 Oligonucleotide compositions and their use to induce differentiation of cells
10/30/2003WO2002083945A3 Diagnosis and treatment of cancer: i
10/30/2003WO2002070741A3 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna
10/30/2003WO2002070547A8 Template-fixed peptidomimetics with antimicrobial activity
10/30/2003WO2002069961A8 Il-8 receptor ligands-drugs for inflammatory and autoimmune diseases
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003WO2002060276A8 Combination of probiotics
10/30/2003WO2002059607A3 Isolation of epidermal stem cells by using the melanoma-associated chondroitin sulfate proteoglycan
10/30/2003WO2002059327A3 Sulfatases and methods of use thereof
10/30/2003WO2002059283A3 Nucleic acid modification enzymes
10/30/2003WO2002056916A3 Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients
10/30/2003WO2002056903A3 Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
10/30/2003WO2002042303A3 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002022819A3 Calcium binding proteins
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003WO2001085995A3 Identification of neural defects associated with the nucleosom al assembly protein 1l2 gene
10/30/2003WO2001074136A3 Telomerase inhibitor polynucleotides
10/30/2003US20030204090 Administering to a patient an indazoline compound to treat cancer, inflammatory disorder or autoimmune disease
10/30/2003US20030204086 Novel heterocyclic amide derivatives
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030204049 Which have affinity/targeting vector for integrin receptors; diagnostic imaging
10/30/2003US20030203975 Such as complex of amino acid/peptide and 1-(2-hydroxyethylamino)anthracene-9,10-dione
10/30/2003US20030203961 A taxane joined by a hydrolyzable bond to one or more oligomers that containing a polyethylene glycol group and a tert-amide group
10/30/2003US20030203957 Selected fused pyrrolocarbazoles
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/30/2003US20030203940 Oxadiazole derivatives having anticancer effects
10/30/2003US20030203938 Epothilone derivatives and their synthesis and use
10/30/2003US20030203933 Novel curcumin analogues and uses thereof
10/30/2003US20030203932 Amonafide salts
10/30/2003US20030203929 Microtubule stabilizing compounds
10/30/2003US20030203927 Thrombin receptor antagonists
10/30/2003US20030203926 For treatment of inflammatory or autoimmune condition, viral infection, cancer
10/30/2003US20030203924 Combination for treating susceptible tumor comprising (S)-2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo(f) quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid and folic acid
10/30/2003US20030203922 Substituted amine derivatives and methods of use
10/30/2003US20030203919 Dipeptide nitrile cathepsin K inhibitors
10/30/2003US20030203916 1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203914 Implicated as playing a key role in processes involving cellular invasion and tissue remodelling including wound repair, bone remodelling, angiogenesis, tumour invasiveness and spread of metastases
10/30/2003US20030203910 A phenoxy-alkyl-quinoxalinone derivatives for inhibiting drug transport proteins that efflux therapeutic agents from cells; synergistic
10/30/2003US20030203907 Novel pyrazinone derivatives
10/30/2003US20030203905 Inhibitors of p38
10/30/2003US20030203904 Antitumor agents for treating cancer
10/30/2003US20030203896 Novel guanidino derivatives as inhibitors of cell adhesion
10/30/2003US20030203894 Pyrimidine derivatives having antitumor effect
10/30/2003US20030203893 Benzimidazole derivatives, preparation and therapeutic use thereof
10/30/2003US20030203882 For treating psoriasis, inflammation, leukemia, colon cancer, breast cancer or prostate cancer
10/30/2003US20030203876 Comprises epothilone in form of infusion concentrate or lyophilised composition
10/30/2003US20030203872 Such as 1-(4-thio-beta-D-arabinofuranosyl)cytosine for treatment of cancer; gene expression inhibition
10/30/2003US20030203870 Method and reagent for the inhibition of NOGO and NOGO receptor genes
10/30/2003US20030203864 Treatment of cancer
10/30/2003US20030203863 Interleukins (IL-2); cytokines; bovine growth hormone; cytomegalovirus; gene therapy
10/30/2003US20030203860 Substituted sugar derivatives of indolopyrrolocarbazoles, useful in inhibiting the proliferatin of tumor cells
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/30/2003US20030203838 Compositions and methods for inhibiting angiogenesis
10/30/2003US20030203836 Methods for reduced renal uptake of protein conjugates
10/30/2003US20030203484 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/30/2003US20030203452 Human chemokine beta-13
10/30/2003US20030203415 Comprises polypeptide for, diagnosis, detection and treatment of cancer
10/30/2003US20030203396 Human galactosyltransferases
10/30/2003US20030203361 13 human colon and colon cancer associated proteins
10/30/2003US20030203055 Administering a selective norepinephrine norepinephrine-serotonin reuptake inhibitor, e.g., milnacipran, that is not a tricylcic antidepressant; gastrointestinal and urogenital disorders; analgesics
10/30/2003US20030203052 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
10/30/2003US20030203051 Plant extracts for the treatment of increased bone resorption
10/30/2003US20030203049 Triterpene compositions and methods for use thereof
10/30/2003US20030203033 Biodegradation organophosphorus polymer; administering to tumor in situ
10/30/2003US20030203030 Polymeric gel delivery system for pharmaceuticals
10/30/2003US20030203014 Positioning solid support into injury; wound healing agents; peptide
10/30/2003US20030203003 Drug releasing biodegradable fiber implant
10/30/2003US20030202991 Delivery of biologically active polypeptides
10/30/2003US20030202985 Methods and compositions for immunotherapy of cancer
10/30/2003US20030202975 Using monoclonal antibodies; shrinkage of solid tumors
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003US20030202959 Polymeric acyl derivatives of indoles
10/30/2003EP1496982A2 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2752132A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/30/2003CA2636960A1 Pharmaceutical composition comprising a specific inhibitor of hedgehog/smoothened signaling and a corticosteroid
10/30/2003CA2483476A1 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003CA2483474A1 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines
10/30/2003CA2483473A1 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/30/2003CA2483409A1 (20s)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin d3 and their uses
10/30/2003CA2483327A1 Oligonucleotides from coding sequences for the surface component of ptlvenvelope proteins and uses thereof
10/30/2003CA2483311A1 Modulators of hedgehog signaling pathways, compositions and uses related thereto
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
10/30/2003CA2482924A1 Adjuvant enhanced immunotherapy
10/30/2003CA2482907A1 Tissue specific genes and gene clusters
10/30/2003CA2482712A1 Compounds useful in preparing camptothecin derivatives
10/30/2003CA2482593A1 Combination of an agent that attenuates topoisomerase 1 activity and an agent that inhibits heat shock protein 90 for use in chemotherapy
10/30/2003CA2482591A1 Combination therapy for the treatment of cancer
10/30/2003CA2482508A1 Combination therapy for the treatment of cancer
1 ... 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 ... 2211